ScholarLens Back to search
2010•European Journal of Heart FailureOpen access

Correspondence Concerning the Article: Is Levosimendan Better than Dobutamine in Acute Heart Failure in Patients on Beta Blockade Treatment? What is the Evidence?

Bernt Gerhard Wikström

Open full text 0 citations

Abstract

Is levosimendan better than dobutamine in acute heart failure in patients on beta

Open-access reader

About this research paper

What this paper is about

Is levosimendan better than dobutamine in acute heart failure in patients on beta

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Is levosimendan better than dobutamine in acute heart failure in patients on beta

Key concepts: Levosimendan, Medicine, Cardiogenic shock, Dobutamine, Clinical endpoint, Heart failure, Cardiology, Acute decompensated heart failure

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Correspondence Concerning the Article: Is Levosimendan Better than Dobutamine in Acute Heart Failure in Patients on Beta Blockade Treatment? What is the Evidence? — Research Paper | ScholarLens